Zobrazeno 1 - 10
of 62
pro vyhledávání: '"William F Glass"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
The same mechanisms that mediate antitumor immunity from checkpoint inhibitors (CPIs) can also lead to unintended targeting of normal tissues, characterized as immune-related adverse events (irAEs). Those with pre-existing autoimmune disease are beli
Externí odkaz:
https://doaj.org/article/bfb4f5e5890f467387404e4d74492a59
Publikováno v:
Leukemia Research Reports, Vol 20, Iss , Pp 100377- (2023)
Membranous nephropathy (MN) is an uncommon renal presentation in patients with chronic lymphocytic leukemia (CLL), and as such, there is no standard therapy for these patients. A few cases of MN in CLL have been described with varying success in MN t
Externí odkaz:
https://doaj.org/article/be111f20ca524f1b9fe105add5ea7eb3
Autor:
Omar Mamlouk, Umut Selamet, Shana Machado, Maen Abdelrahim, William F. Glass, Amanda Tchakarov, Lillian Gaber, Amit Lahoti, Biruh Workeneh, Sheldon Chen, Jamie Lin, Noha Abdel-Wahab, Jean Tayar, Huifang Lu, Maria Suarez-Almazor, Nizar Tannir, Cassian Yee, Adi Diab, Ala Abudayyeh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Rationale & Objective The approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including treatment in the adjuvant setting, the immune related toxicities associated with CPI can limit the efficacy of
Externí odkaz:
https://doaj.org/article/9b7f1d1554de4916904fb600cac6c367
Background Membranous nephropathy (MN) is an uncommon renal presentation in patients with chronic lymphocytic leukemia (CLL), and as such, there is no standard therapy for these patients. Ibrutinib, a small molecule kinase inhibitor that irreversibly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4190129361d697092f8d6881171150
https://doi.org/10.21203/rs.3.rs-2347314/v1
https://doi.org/10.21203/rs.3.rs-2347314/v1
Autor:
Praveen Ratanasrimetha, Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel, Jamie S. Lin
Publikováno v:
Frontiers in Immunology. 13
BackgroundDiagnosing immune checkpoint inhibitor (ICI)-associated nephritis can be challenging since it is a rare complication of therapy, associated with a spectrum of immune-mediated pathologies, and can present months after ICI therapy discontinua
Autor:
João Quevedo, Colin Carlock, Yahuan Lou, Jean Wu, Tatiana Barichello, William F Glass, April Ross, Junbo Shim, Ines Moreno-Gonzalez
Publikováno v:
Molecular Psychiatry
Defective aquaporin4 (AQP4)-mediated glymphatic drainage has been linked to tauopathy and amyloid plaque in Alzheimer’s disease. We now show that brain interleukin33 (IL33) is required for regulation of AQP4 expression in astrocytes, especially tho
Publikováno v:
CEN Case Reports. 9:147-151
We present a 61-year-old male with FLT3-mutated acute myeloid leukemia treated with midostaurin who developed acute kidney injury requiring hemodialysis and pulmonary renal syndrome. Antibodies to proteinase-3, myeloperoxidase, and glomerular basemen
Publikováno v:
Pathology. 51:762-764
Autor:
Ala Abudayyeh, Cassian Yee, Nizar M. Tannir, Maria E. Suarez-Almazor, Shana Machado, Biruh Workeneh, Sheldon Chen, Amanda Tchakarov, Umut Selamet, Lillian W. Gaber, Huifang Lu, William F Glass, Amit Lahoti, Omar Mamlouk, Jamie S. Lin, Noha Abdel-Wahab, Maen Abdelrahim, Jean Tayar, Adi Diab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Rationale & Objective The approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including treatment in the adjuvant setting, the immune related toxicities associated with CPI can limit the efficacy of these age
Autor:
Adi Diab, Umut Selamet, Maen Abdelrahim, Rahul A. Sheth, Amanda Tchakarov, Ala Abudayyeh, Cassian Yee, Omar Mamlouk, Jamie S. Lin, Rachel M. Layman, Noha Abdel-Wahab, William F. Glass, Ramona Dadu
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
Acute tubular interstitial nephritis (ATIN) is the most frequently reported pathology in patients with checkpoint inhibitor (CPI) induced acute kidney injury (AKI). Glucocorticoid (GC) therapy and discontinuation of CPI are the mainstay of treatment